Ezetimibe combination therapy with statin for non-alcoholic fatty liver disease: an open-label randomized controlled trial (ESSENTIAL study)

• 資料種別: 記事
• タイトル: Ezetimibe combination therapy with statin for non-alcoholic fatty liver disease: an open-label randomized controlled trial (ESSENTIAL study)
• 著者標目: Yongin Cho; Hyungjin Rhee; Young-eun Kim; Minyoung Lee; Byung-Wan Lee; Eun Seok Kang; Bong-Soo Cha; Jin-Young Choi; Yong-ho Lee
• 出版年月日等: 2022-03-21
• 出版年（W3CDTF）: 2022-03-21
• タイトル（掲載誌）: BMC Medicine
• 巻号年月日等（掲載誌）: 20 1
• 掲載巻: 20
• 掲載号: 1
• 掲載年月日（W3CDTF）: 2022-03-21
• 出版事項（掲載誌）: Springer Science and Business Media LLC
• 対象利用者: 一般
• DOI: 10.1186/s12916-022-02288-2; https://doi.org/10.1186/s12916-022-02288-2
• 作成日（W3CDTF）: 2022-03-21
• 著作権情報: https://creativecommons.org/licenses/by/4.0
• 関連情報（URI）: https://link.springer.com/content/pdf/10.1186/s12916-022-02288-2.pdf; https://link.springer.com/article/10.1186/s12916-022-02288-2/fulltext.html
• 参照: Metabolic dysfunction-associated fatty liver disease increases risk of chronic kidney disease: a systematic review and meta-analysis; https://cir.nii.ac.jp/crid/1360584339779045632
• 連携機関・データベース: 国立情報学研究所 : CiNii Research; https://cir.nii.ac.jp/
• 提供元機関・データベース: Crossref; https://www.crossref.org

• 要約等: <jats:title>Abstract</jats:title><jats:sec> <jats:title>Background</jats:title> <jats:p>The effect of ezetimibe, Niema...